ECCO 2022
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
ECCO IBD by OCEAiN Organisation, Congress, Emotion, Association, iNnovation GmbH
European Crohn´s and Colitis Organisation - ECCO - ECCO'23
European Crohn´s and Colitis Organisation - ECCO - Home
Apostolis Papaefthymiou on LinkedIn: A cutting edge review for IBD related NAFLD (IBDAFLD). This is a real…
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
20 20 Vision in IBD - European Medical Journal
Y-ECCO (@Y_ECCO_IBD) / Twitter
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
European Crohn´s and Colitis Organisation - ECCO - JCC – Journal of Crohn's and Colitis
Journal of Crohn's and Colitis | ScienceDirect.com by Elsevier
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics? | American Journal of Physiology-Gastrointestinal and Liver Physiology
Mistakes in opportunistic infections and vaccinations in IBD and how to avoid them | UEG - United European Gastroenterology
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Topical Reviews
Metabolites | Free Full-Text | What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature
Y-ECCO (@Y_ECCO_IBD) / Twitter
Journal of Crohn's and Colitis | Includes Abstracts of the 4th Congress of ECCO | ScienceDirect.com by Elsevier
ClinicalThought: New Data from ECCO 2022 - ClinicalThought - ECCO 2022 | CCO
ECCO
Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY
Welcome to the Journal of Crohn's & Colitis
ECCO 2021 - New Data On Therapy For Severely Active Ulcerative Colitis - YouTube
European Crohn´s and Colitis Organisation - ECCO - ECCO News
JCM | Conferences
